Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) successfully hosted the “Breast Cancer Update Conference 2024” held on June 15 and 16, 2024. The conference brought together leading experts, researchers, healthcare professionals and faculty from India and abroad to explore the recent breakthroughs in breast cancer research. The two-day event highlighted critical findings from the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and San Antonio Breast Cancer Symposium (SABCS).
The conference held under the patronage of the chairman Rakesh Chopra featured expert-led sessions on emerging therapies, precision medicine, and patient-centered care, along with panel discussions and interactive workshops designed to foster knowledge exchange and collaboration. Topics included – early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine.
Renowned oncologists presented significant findings from recent studies and latest trials on targeted therapies, immunotherapy like Pembrolizumab, cyclin inhibitor tablets and many new drugs and surgical procedures along with radiation techniques and investigations which have made revolutionary changes in the outcome of breast cancer management. These presentations provided valuable insights into innovative treatments and patient care strategies.
Interactive panel discussions allowed for exchanges of ideas and experiences among top oncologists, researchers, and clinicians. Panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.